Alzamend Neuro, Inc.ALZNNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank100
5Y CAGR+36.2%
Year-over-Year Change
Year-over-year operating income growth rate
5Y CAGR
+36.2%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
4.7x
Strong expansion
Streak
3 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 54.75% |
| 2024 | 33.17% |
| 2023 | -20.70% |
| 2022 | -148.79% |
| 2021 | -11.93% |
| 2020 | 11.68% |
| 2019 | -457.80% |
| 2018 | 41.99% |
| 2017 | -2128.75% |
| 2016 | 0.00% |